A family of Pseudohypoparathyroidism: report on a family with affected three members
DOI:
https://doi.org/10.37506/55ff1r93Keywords:
Parathyroid hormone (PTH), Pseudohypoparathyroidism (PHP), iPPSD: inactivating PTH/PTH-related protein signalling disorder.Abstract
Pseudohypoparathyroidism (PHP) represents a group of disorders due to end organ resistance to the actions of parathyroid hormone (PTH) and abnormalities in the PTH signalling pathway. PHP is characterized by hypocalcaemia and hyperphosphataemia, with or without a variable expression of physical features. The constellations of these physical features together are termed Albright hereditary osteodystrophy (AHO). PHP and related disorders are primarily clinical diagnoses in our setting as confirmatory laboratory testing is not widely available. Molecular genetics is the gold standard for confirmation and categorization of PHP into the different subtypes, but with recent advances in molecular diagnostics a pathophysiological approach appears to be more practical in the clinical setting. We present here the clinical course of a family of Pseudohypoparathyroidism who have been followed up at Paediatric Department of our hospital. The cases responded well with calcium and calcitriol supplementation without access to genetic testing in our hospital.
References
Thiele S, Mantovani G, Barlier A, Boldrin V, Bordogna P, De Sanctis L, Elli FM, Freson K, Garin I, Grybek V, Hanna P, Izzi B, Hiort O, Lecumberri B, Pereda A, Saraff V, Silve C, Turan S, Usardi A, Werner R, de Nanclares GP, Linglart A. From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network. Eur J Endocrinol. 2016 Dec;175(6):P1-P17. doi: 10.1530/EJE-16-0107. Epub 2016 Jul 11. PMID: 27401862.
Turan S. Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder. J Clin Res Pediatr Endocrinol. 2017 Dec 30;9(Suppl 2):58-68. doi: 10.4274/jcrpe.2017.S006. Epub 2017 Dec 27. PMID: 29280743; PMCID: PMC5790322.
NCBI Genome Data Viewer. U.S National Library of Medicine. PRKAR1A protein kinase c-AMP- dependent type 1 regulatory subunit alpha. National Center for Biotech. Information. [Updated 2019 Dec 20; cited 2020 Jan 21]. ncbi.nlm.nih.gov/gene/5573.
Albright F, Burnett C, Smith PH, Parson W. Pseudohypoparathyroidism: an example of “Seabright-Bantam syndrome” Endocrinology. 1942;30(6):922–932.
Levine MA. An update on the clinical and molecular characteristics of pseudohypoparathyroidism. Curr Opin Endocrinol Diabetes Obes. 2012 Dec;19(6):443-51. doi: 10.1097/MED.0b013e32835a255c. PMID: 23076042; PMCID: PMC3679535.
Haldeman-Englert CR, Hurst ACE, Levine MA. Disorders of GNAS Inactivation. 2017 Oct 26. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459117/
Roizen JD, Danzig J, Groleau V, McCormack S, Casella A, Harrington J, Sochett E, Tershakovec A, Zemel BS, Stallings VA, Levine MA. Resting Energy Expenditure Is Decreased in Pseudohypoparathyroidism Type 1A. J Clin Endocrinol Metab. 2016 Mar;101(3):880-8. doi: 10.1210/jc.2015-3895. Epub 2015 Dec 28. PMID: 26709970; PMCID: PMC4803160.
Chen M, Shrestha YB, Podyma B, Cui Z, Naglieri B, Sun H, Ho T, Wilson EA, Li YQ, Gavrilova O, Weinstein LS. Gsα deficiency in the dorsomedial hypothalamus underlies obesity associated with Gsα mutations. J Clin Invest. 2017 Feb 1;127(2):500-510. doi: 10.1172/JCI88622. Epub 2016 Dec 19. PMID: 27991864; PMCID: PMC5272175.
Thiele S, de Sanctis L, Werner R, Grötzinger J, Aydin C, Jüppner H, Bastepe M, Hiort O. Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gsα-receptor interaction. Hum Mutat. 2011 Jun;32(6):653-60. doi: 10.1002/humu.21489. Epub 2011 Apr 12. PMID: 21488135; PMCID: PMC3103608
Mantovani G. Clinical review: Pseudohypoparathyroidism: diagnosis and treatment. J Clin Endocrinol Metab. 2011 Oct;96(10):3020-30. doi: 10.1210/jc.2011-1048. Epub 2011 Aug 3. PMID: 21816789.
Martos-Moreno GÁ, Lecumberri B, Pérez de Nanclares G. Implicaciones en pediatría del primer consenso internacional para el diagnóstico y asistencia a pacientes con pseudohipoparatiroidismo y enfermedades relacionadas [Implication in Paediatrics of the First International Consensus Statement for the Diagnosis and management of pseudohypoparathyroidism and related disorders]. An Pediatr (Engl Ed). 2019 Feb;90(2):125.e1-125.e12. Spanish. doi: 10.1016/j.anpedi.2018.11.014. Epub 2018 Dec 24. PMID: 30591400.
Madi N, Moosa FY, Parbhoo KB, Pettifor JM, Thandrayen K. Pseudohypoparathyroidism presenting in children at a tertiary hospital in Johannesburg, South Africa, Journal of Endocrinology, Metabolism and Diabetes of South Africa 2020; 25:3:82-89. DOI: 10.1080/16089677.2020.1817282
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
https://creativecommons.org/licenses/by-nc/2.0/deed.en